Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $13.79 million. The enterprise value is $14.80 million.
Important Dates
The last earnings date was Tuesday, October 28, 2025, after market close.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 2.61 million shares outstanding. The number of shares has increased by 73.41% in one year.
| Current Share Class | 2.61M |
| Shares Outstanding | 2.61M |
| Shares Change (YoY) | +73.41% |
| Shares Change (QoQ) | +20.00% |
| Owned by Insiders (%) | 2.96% |
| Owned by Institutions (%) | 3.38% |
| Float | 2.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | 0.58 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.66 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -51.86 |
Financial Efficiency
Return on equity (ROE) is -85.01% and return on invested capital (ROIC) is -38.52%.
| Return on Equity (ROE) | -85.01% |
| Return on Assets (ROA) | -27.15% |
| Return on Invested Capital (ROIC) | -38.52% |
| Return on Capital Employed (ROCE) | -86.83% |
| Revenue Per Employee | $223,470 |
| Profits Per Employee | -$158,091 |
| Employee Count | 66 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.67% in the last 52 weeks. The beta is 1.11, so EKSO's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -68.67% |
| 50-Day Moving Average | 4.53 |
| 200-Day Moving Average | 5.46 |
| Relative Strength Index (RSI) | 58.53 |
| Average Volume (20 Days) | 46,604 |
Short Selling Information
The latest short interest is 102,908, so 3.94% of the outstanding shares have been sold short.
| Short Interest | 102,908 |
| Short Previous Month | 101,367 |
| Short % of Shares Out | 3.94% |
| Short % of Float | 4.58% |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, EKSO had revenue of $14.75 million and -$10.43 million in losses. Loss per share was -$5.22.
| Revenue | 14.75M |
| Gross Profit | 7.89M |
| Operating Income | -11.05M |
| Pretax Income | -10.43M |
| Net Income | -10.43M |
| EBITDA | -9.53M |
| EBIT | -11.05M |
| Loss Per Share | -$5.22 |
Full Income StatementBalance Sheet
The company has $2.72 million in cash and $4.96 million in debt, giving a net cash position of -$2.23 million or -$0.85 per share.
| Cash & Cash Equivalents | 2.72M |
| Total Debt | 4.96M |
| Net Cash | -2.23M |
| Net Cash Per Share | -$0.85 |
| Equity (Book Value) | 9.68M |
| Book Value Per Share | 3.69 |
| Working Capital | 5.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.90 million and capital expenditures -$83,000, giving a free cash flow of -$8.99 million.
| Operating Cash Flow | -8.90M |
| Capital Expenditures | -83,000 |
| Free Cash Flow | -8.99M |
| FCF Per Share | -$3.44 |
Full Cash Flow StatementMargins
Gross margin is 53.48%, with operating and profit margins of -74.90% and -70.74%.
| Gross Margin | 53.48% |
| Operating Margin | -74.90% |
| Pretax Margin | -70.74% |
| Profit Margin | -70.74% |
| EBITDA Margin | -64.59% |
| EBIT Margin | -74.90% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.41% |
| Shareholder Yield | -73.41% |
| Earnings Yield | -83.06% |
| FCF Yield | -71.53% |
Analyst Forecast
The average price target for EKSO is $34.75, which is 558.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.75 |
| Price Target Difference | 558.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
